NITI Aayog on Monday launched two transformative initiatives, AI for Viksit Bharat Roadmap: Opportunity for Accelerated Economic Growth and NITI Frontier Tech Repository under its Frontier Tech Hub.

Learn about the government's decision to lower GST on drugs and medical devices, effective from September 22, 2025, and how it impacts product ...

The government has clarified that medicines already in the supply chain before September 22, 2025, will not need to be ...

CBIC said the National Pharmaceutical Pricing Authority (NPPA) has directed all drug manufacturers and marketing companies to ...

NPPA directs firms to issue revised price lists instead of recalling stock; compliance to be ensured at retailer level ...

Recalling, re-labelling, or re-stickering on the label of a container or pack of stocks released in the market prior to ...

In a major relief for the pharma sector, the government has dismissed the mandatory rule for drug manufacturers to recall, or ...

The National Pharmaceutical Pricing Authority (NPPA) has clarified that, instead of recalling or re-labelling, manufacturers ...

This follows the latest revision in Goods and Services Tax (GST) rates early this month by the GST Council, which reduced the GST on medical devices to 5 per cent from 12 per cent.

Jharkhand DC issues guidelines on MRP revisions of medicines post-GST amendments: Peethaambaran Kunnathoor, Chennai Thursday, September 11, 2025, 08:00 Hrs [IST] In response to th ...

This move comes after the GST Council ’s sweeping reforms on September 3, which reduced taxes on several healthcare products.

Since existing stock is already in the distribution pipeline, it may take two–three months for the transition to be fully ...